An investment of Rs 800 crore will be made by Bristol Myers Squibb, the top pharmaceutical business in the world, to build this state-of-the-art facility, according to a Telangana government press release. The declaration was made following a meeting between Samit Hirawat, Executive Vice-President, Global Drug Development at BMS, and Telangana Minister KT Rama Rao. Hirawat was in the city to attend BioAsia 2023. According to a BMS announcement, the business intends to launch operations in Hyderabad later in 2023, with the potential to hire 1,500 individuals over the following few years to work on cutting-edge R&D and digital projects. Rama Rao said, “I am delighted to welcome Bristol Myers Squibb to the vibrant ecosystem of Hyderabad. It is indeed a matter of pride that BMS, which is one of the most innovative and world leading biopharmaceutical companies, has chosen Hyderabad and I strongly believe this partnership with BMS is a strategic one.”
